These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10203776)

  • 1. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks.
    Prazeres DM; Ferreira GN; Monteiro GA; Cooney CL; Cabral JM
    Trends Biotechnol; 1999 Apr; 17(4):169-74. PubMed ID: 10203776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale purification of pharmaceutical-grade plasmid DNA using tangential flow filtration and multi-step chromatography.
    Sun B; Yu X; Yin Y; Liu X; Wu Y; Chen Y; Zhang X; Jiang C; Kong W
    J Biosci Bioeng; 2013 Sep; 116(3):281-6. PubMed ID: 23660074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A united front.
    Nature; 2011 Apr; 472(7344):389-90. PubMed ID: 21525888
    [No Abstract]   [Full Text] [Related]  

  • 4. Scaleable processes for the manufacture of therapeutic quantities of plasmid DNA.
    Shamlou PA
    Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):207-18. PubMed ID: 12683955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upstream processing of plasmid DNA for vaccine and gene therapy applications.
    Tejeda-Mansir A; Montesinos RM
    Recent Pat Biotechnol; 2008; 2(3):156-72. PubMed ID: 19075863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials.
    Horn NA; Meek JA; Budahazi G; Marquet M
    Hum Gene Ther; 1995 May; 6(5):565-73. PubMed ID: 7578394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccine manufacture: scale and quality.
    Cai Y; Rodriguez S; Hebel H
    Expert Rev Vaccines; 2009 Sep; 8(9):1277-91. PubMed ID: 19722898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid DNA production for pharmaceutical use: role of specific growth rate and impact on process design.
    Bohle K; Ross A
    Biotechnol Bioeng; 2011 Sep; 108(9):2099-106. PubMed ID: 21437880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on plasmid-based gene therapy: challenges for the product and the process.
    Kelly WJ
    Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):219-23. PubMed ID: 12672266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid DNA production combining antibiotic-free selection, inducible high yield fermentation, and novel autolytic purification.
    Carnes AE; Hodgson CP; Luke JM; Vincent JM; Williams JA
    Biotechnol Bioeng; 2009 Oct; 104(3):505-15. PubMed ID: 19557837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmid DNA manufacturing technology.
    Carnes AE; Williams JA
    Recent Pat Biotechnol; 2007; 1(2):151-66. PubMed ID: 19075838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of plasmids for gene therapy and DNA vaccination.
    Prazeres DM; Monteiro GA; Ferreira GN; Diogo MM; Ribeiro SC; Cabral JM
    Biotechnol Annu Rev; 2001; 7():1-30. PubMed ID: 11686041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes.
    Williams JA; Luke J; Langtry S; Anderson S; Hodgson CP; Carnes AE
    Biotechnol Bioeng; 2009 Aug; 103(6):1129-43. PubMed ID: 19408315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid DNA for pharmaceutical applications.
    Schleef M; Schmidt T; Flaschel E
    Dev Biol (Basel); 2000; 104():25-31. PubMed ID: 11713820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scale-Up of Plasmid DNA Downstream Process Based on Chromatographic Monoliths.
    Černigoj U; Štrancar A
    Methods Mol Biol; 2021; 2197():167-192. PubMed ID: 32827137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality-by-design for biotechnology-related pharmaceuticals.
    Mandenius CF; Graumann K; Schultz TW; Premstaller A; Olsson IM; Petiot E; Clemens C; Welin M
    Biotechnol J; 2009 May; 4(5):600-9. PubMed ID: 19418475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic solvents in the pharmaceutical industry.
    Grodowska K; Parczewski A
    Acta Pol Pharm; 2010; 67(1):3-12. PubMed ID: 20210074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of process flow sheets for the purification of supercoiled plasmids for gene therapy applications.
    Ferreira GN; Cabral JM; Prazeres DM
    Biotechnol Prog; 1999; 15(4):725-31. PubMed ID: 10441364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-process testing and limits.
    Sjöholm I
    Dev Biol Stand; 1997; 91():73-8. PubMed ID: 9413685
    [No Abstract]   [Full Text] [Related]  

  • 20. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.